Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: Jim Lamb who wrote (6730)	1/18/1999 2:46:00 AM
From: Anthony Wong	Read Replies (2) \| Respond to of 9523

New pill takes on Viagra South China Morning Post Monday January 18 1999 REUTERS A company aims to capitalise on the international success of Viagra by marketing its own anti-impotence drug under the same Chinese name. A branch of Feilong (Hong Kong) Group planned to start selling its self-developed treatment Weige Kaitai next Monday in Liaoning's provincial capital Shenyang, yesterday's China Daily said. Weige - "great man" - is the familiar word for Viagra. Viagra, manufactured by US firm Pfizer, has not been approved for sale in China, but has earned a reputation as a miracle impotence cure. Nearly 600 men are taking Viagra in clinical trials as authorities evaluate the drug for import. The Government plans to announce a decision before the end of the year. But Feilong has a head start on tapping the country's vast market of impotent men. "The existence of the Weige Kaitai pill will certainly influence the sales of Viagra in China if it is approved for import," the paper quoted an official with the Trademark Office as saying. Feilong boss Jiang Wei, the Chinese drug's inventor, did not know of any challenges to his registration of the Weige Kaitai trademark.

To: Jim Lamb who wrote (6730)	1/18/1999 11:11:00 PM
From: BigKNY3	Read Replies (2) \| Respond to of 9523

Viagra 's Popular, But Most Consumers Don't Remember Drug Names 01/18/99 Dow Jones Business News NEW YORK -(Dow Jones)- U.S. consumers recognize the name of Pfizer Inc.'s Viagra more than any other drug, and Merck & Co. Inc. has the most-recognizable corporate name in the business, according to a survey released Monday. But for the most part, the names of drugs and drugmakers don't stick with Americans at all, the study shows. Scott-Levin, a Newtown, Pa.-based market-research firm, surveyed 1,400 consumers in its annual study. Scott Levin is a unit of PMSI Scott-Levin Inc., which recently agreed to be acquired by Quintiles Transnational Corp. (QTRN). Only 37% of the consumers could recall any product names from news stories, and only 23% were able to name a specific drug company. Consumers were more likely to be able to mention a product or company by name if they were chronic users of prescription drugs, 55 or older, college graduates, or medically educated. The name Viagra , the blockbuster impotence drug that Pfizer (PFE) put on the market last year, was recognized by 34% of the respondents in Scott-Levin's survey. Next was Pondimin, the brand name of fenfluramine, the diet drug sold by American Home Products Corp.'s (AHP) Wyeth-Ayerst. The drug, which was pulled off the market in 1997 after medical studies found a link to heart disease, was recognized by 8% of those surveyed. Schering-Plough Corp.'s (SGP) antihistamine Claritin was recognized by 7%, while 5% said they had heard of Eli Lilly & Co.'s (LLY) antidepressant Prozac. The most-recognized drug makers were Merck (MRK), at 13%; Pfizer, at 12%; Lilly, at 9%; Bristol-Myers Squibb Co. (BMY), at 8%; Glaxo Wellcome PLC (GLX), at 6%; and American Home Products, at 5%.